Celsius Shares Maintain Upward Trajectory Amid Operational Progress

Celsius Holdings continues to advance, with its stock rally finding support from clarified regulatory filings and sustained analyst confidence. As concerns over insider disclosures have been resolved, the market’s attention is shifting to the company's operational milestones, including the integration of Alani Nu and its expanded distribution partnership with PepsiCo. The central question for investors is whether this positive momentum can be converted into sustained revenue expansion.

The recent share price appreciation is largely attributed to two key developments. First, a corrected disclosure from director William H. Milmoe has clarified misconceptions regarding previous stock transactions. The amended Form 4/A filing indicates that approximately 1.32 million shares, previously reported in a manner that caused confusion, were actually settlements of a prepaid variable forward (VPF) contract established in January 2023. This correction effectively dispelled interpretations of recent discretionary selling, thereby reducing a layer of investor uncertainty.

Concurrently, analysts have reaffirmed their bullish stance. Needham, in early January, reiterated its positive outlook, citing an accelerated sales trajectory powered by PepsiCo's extensive distribution network. The firm reported that over 80% of Alani Nu's direct-store-delivery (DSD) business had been transitioned to PepsiCo by early December 2025. These tangible operational advances are rebuilding investor trust in the Celsius equity story.

Should investors sell immediately? Or is it worth buying Celsius?

Valuation Premium Presents a Dual Narrative

Despite the powerful momentum, Celsius trades at a notable valuation premium. With a price-to-sales multiple of 6.38x, it stands significantly above the industry average of 1.94x. While high growth expectations and a robust return on equity of 41.88% justify part of this premium, they also leave the stock vulnerable to any earnings disappointments. Providing a measure of support is an authorized share repurchase program worth $300 million, which can help stabilize the price during periods of market volatility.

The stock currently trades at $52.61. Year-to-date performance sits at approximately 10.2%, while the 12-month return is an impressive 95.8%. From a technical perspective, the price action above both short and long-term moving averages, accompanied by rising trading volumes, suggests institutional accumulation. The consensus analyst rating remains "Moderate Buy," with an average 12-month price target of $63.89.

The Forthcoming Catalyst: Annual Guidance

All eyes are now on the upcoming release of preliminary 2025 annual results. The critical factor will be whether Celsius can confirm its target of roughly 30% year-over-year revenue growth. Success will increasingly depend on contributions from the company's expansion into the United Kingdom and Ireland. In the near term, the $52.61 price zone serves as a technical support level. Confirmation of the growth target would reinforce the current analyst outlook, whereas any shortfall could place downward pressure on the stock's elevated valuation multiples.